TREA

87150012 - ORABODY

Follow

Information

  • Trademark
  • 87150012
  • Serial Number
    87150012
  • Registration Number
    5336498
  • Filing Date
    August 24, 2016
    8 years ago
  • Registration Date
    November 14, 2017
    7 years ago
  • Transaction Date
    November 16, 2023
    a year ago
  • Status Date
    November 15, 2023
    a year ago
  • Published for Opposition Date
    January 10, 2017
    8 years ago
  • Location Date
    November 15, 2023
    a year ago
  • First Use Anywhere Date
    December 28, 2015
    9 years ago
  • First Use In Commerce Date
    August 01, 2016
    8 years ago
Information
Mark Drawing Code
4000
Mark Identification
ORABODY
Case File Statements
  • GS0051: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer
Case File Event Statements
  • 11/15/2023 - a year ago
    22 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8
  • 11/15/2023 - a year ago
    21 - REGISTERED - SEC. 8 (6-YR) ACCEPTED Type: 8.OK
  • 11/9/2023 - a year ago
    20 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 11/21/2022 - 2 years ago
    19 - OFFICE ACTION ISSUED POU1 Type: PUM1
  • 11/20/2022 - 2 years ago
    18 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/15/2022 - 2 years ago
    17 - TEAS SECTION 8 RECEIVED Type: ES8R
  • 11/14/2022 - 2 years ago
    16 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 11/14/2017 - 7 years ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/12/2017 - 7 years ago
    14 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/11/2017 - 7 years ago
    13 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 9/18/2017 - 7 years ago
    12 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 9/1/2017 - 7 years ago
    11 - USE AMENDMENT FILED Type: IUAF
  • 9/18/2017 - 7 years ago
    10 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/1/2017 - 7 years ago
    9 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 3/8/2017 - 8 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/10/2017 - 8 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/10/2017 - 8 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/21/2016 - 8 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/4/2016 - 8 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/4/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/30/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/27/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP